Concepedia

Adèle Mangelinck

AM

Statistics

Publications

8

Citations

147

H-Index

8

Active since

2019

Affiliations

Université Paris-Saclay(Current)

Centre National de la Recherche Scientifique

Inserm

CEA Paris-Saclay

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Adèle Mangelinck is an author at Université Paris-Saclay specializing in genetics, epigenetics, and gene expression.

ORCID

Top concepts

Publications per year

2019–2024

8

Publications

8

MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma

Adèle Mangelinck, Maria Eugénia Marques Da Costa, Bojana Stefanovska et al. · Scientific Reports · 2019 · 30 citations · Full text

Reduced RNA turnover as a driver of cellular senescence

Nowsheen Mullani, Yevheniia Porozhan, Adèle Mangelinck et al. · Life Science Alliance · 2021 · 29 citations · Full text

Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma

Adèle Mangelinck, Nadia Habel, Audrey Mohr et al. · Cancers · 2021 · 21 citations · Full text

Histone Variant H2A.J Is Enriched in Luminal Epithelial Gland Cells

Christophe E. Redon, Zoé Schmal, Gargi Tewary et al. · Genes · 2021 · 15 citations · Full text

The H2A.J histone variant contributes to Interferon-Stimulated Gene expression in senescence by its weak interaction with H1 and the derepression of repeated DNA sequences

Adèle Mangelinck, C Coudereau, Régis Courbeyrette et al. · 2020 · 14 citations · Full text

, , +19

1–5 of 8